Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla Ajanta Pharma Limited
| Okres |
2023-03-31 |
2024-03-31 |
2025-03-31 |
2026-03-31 |
2027-03-31 |
| Przychód (średnia) |
38,175.50 |
42,087.10 |
47,288.67 |
53,015.50 |
54,810.00 |
| Przychód Δ r/r |
0.00% |
10.25% |
12.36% |
12.11% |
3.38% |
| Przychód (min) |
36,506.72 |
42,087.10 |
47,288.67 |
53,015.50 |
54,810.00 |
| Przychód (max) |
40,226.30 |
42,087.10 |
47,288.67 |
53,015.50 |
54,810.00 |
| EBITDA (średnia) |
11,967.76 |
13,770.20 |
15,735.62 |
15,839.28 |
16,375.42 |
| EBIT (średnia) |
8,386.34 |
9,649.39 |
11,026.64 |
13,894.53 |
14,364.84 |
| EBIT % |
21.97% |
22.93% |
23.32% |
26.21% |
26.21% |
| Zysk netto (średni) |
6,718.67 |
8,161.70 |
9,457.30 |
11,073.70 |
10,590.00 |
| Zysk netto % |
17.60% |
19.39% |
20.00% |
20.89% |
19.32% |
| EPS (średnia) |
50.14 |
64.82 |
74.67 |
87.43 |
84.10 |
| Liczba analityków (Przychody) |
8 |
10 |
9 |
10 |
1 |
| Liczba analityków (EPS) |
9 |
10 |
10 |
10 |
1 |
| symbol |
AJANTPHARM.NS |
AJANTPHARM.NS |
AJANTPHARM.NS |
AJANTPHARM.NS |
AJANTPHARM.NS |